TRICYCLIC PYRAZOLO-PYRIDINE KINASE INHIBITOR

PROBLEM TO BE SOLVED: To provide a protein kinase inhibitor.SOLUTION: Considering the current unsatisfactory medical treatment applied to majority of disorders related to activation of PKC- , it is important to develop a useful compound as PKC- inhibitor. The present invention relates to a useful co...

Full description

Saved in:
Bibliographic Details
Main Authors PHILIP COLLIER, DAVIS CHRIS, BOYALL DEAN, MILLER ANDREW, SETTIMO LUCA, DAMIEN FRAYSSE, JOHN STUDLEY, JIMENEZ JUAN-MIGUEL, YOUNG STEVEN, KNEGTEL RONALD, GUY BRENCHLEY, HEATHER TWIN
Format Patent
LanguageEnglish
Japanese
Published 06.11.2014
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:PROBLEM TO BE SOLVED: To provide a protein kinase inhibitor.SOLUTION: Considering the current unsatisfactory medical treatment applied to majority of disorders related to activation of PKC- , it is important to develop a useful compound as PKC- inhibitor. The present invention relates to a useful compound as protein kinase inhibitor. The present invention also provides a pharmaceutically acceptable composition including the compound and an application method of the composition in medical treatment of various diseases, conditions, and disorders. The present invention also provides a method for preparing the compound. 【課題】プロテインキナーゼの阻害剤を提供すること。【解決手段】ＰＫＣ−θの活性化に関係した障害の大部分に現在利用されている治療が不十分なものであることを考えれば、ＰＫＣ−θの阻害剤として有用な化合物を開発することは重要である。本発明は、プロテインキナーゼの阻害剤として有用な化合物に関する。本発明は、前記化合物を含む薬学的に許容される組成物、および様々な疾患、状態または障害の治療における組成物の使用方法も提供する。本発明は、本発明の化合物を調製するための方法も提供する。【選択図】なし
Bibliography:Application Number: JP20140163360